首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Journal of pharmacokinetics and pharmacodynamics

缩写:J PHARMACOKINET PHAR

ISSN:1567-567X

e-ISSN:1573-8744

IF/分区:2.8/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引898
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Günter Heimann,Thomas Dumortier,Karin Meiser Günter Heimann
PK-QTc analyses are an integral part of drug development programs. These analyses are often based on phase I study data, and the question may be asked whether the design of these phase I studies has an impact on the precision of the corresp...
Verena Gotta,Birgit Donner Verena Gotta
Prolongation of the QT interval in the ECG is a critical finding that signifies an extended duration from the onset of ventricular depolarization to the end of ventricular repolarization. It can predispose patients to life-threatening arrhy...
Zhonghui Huang,Matthew Fidler,Minshi Lan et al. Zhonghui Huang et al.
Nonlinear mixed-effects models rely on adequate initial parameter estimates for efficient parameter optimization. Poor initial estimates can result in failed model convergence or termination with incorrect parameter estimates. Non-compartme...
Keyur R Parmar,Agnish Dey,Angelia F Wang et al. Keyur R Parmar et al.
Despite tremendous clinical responses and patient benefit in hematological malignancies, chimeric Antigen Receptor (CAR) T cells have demonstrated limited success in solid tumors. Herein, we have scaled and augmented our previously describe...
Eric L Haseltine,Violeta Rodriguez-Romero Eric L Haseltine
Solving models comprised of nonlinear differential equations (DEs) in NONMEM using ADVAN6 or ADVAN13 typically requires substantially longer run times than models comprised of linear DEs, which in some cases allow for analytical solutions. ...
David S Ross,Antonio Cabal David S Ross
When a tumor is treated with an antibody-drug conjugate (ADC) complex biochemistry occurs in a domain-the tumor-whose size and structure are changing. Some parts of the tumor may be growing because tumor cells proliferate. Other parts may b...
Amruta Gajanan Bhat,Euibeom Shin,Amit Roy et al. Amruta Gajanan Bhat et al.
Model-informed drug development (MIDD) is a framework that utilizes quantitative modeling and simulation methods to integrate nonclinical and clinical data, as well as prior knowledge, to inform drug development and regulatory decision-maki...
Summer Feng,Rudy Gunawan,Chaitali Passey et al. Summer Feng et al.
Tisotumab vedotin (TV), a tissue factor-directed antibody-drug conjugate (ADC), is approved in the US at 2.0 mg/kg every 3 weeks (Q3W) for adult patients with recurrent or metastatic cervical cancer following disease progression on or after...
Rong Chen,Mark Sale,Alex Mazur et al. Rong Chen et al.
Automatic differentiation (AD), a key method for accurately and efficiently computing derivatives in modern machine learning, is now implemented in Phoenix® NLME™ 8.6 for the first time and applied to the first-order conditional estimatio...